BRIEF-Crossject delays filing of marketing authorization for Zénéo Adrenaline

* Due to a delay in bioequivalence study led by its customer, filing of marketing

authorization for Zénéo Adrenaline should be delayed several months as well

Source text for Eikon:

Further company coverage:

(Gdynia Newsroom)

Read more